Cancer patients who usually get treatment in Summerside will have to travel to P.E.I.'s capital over the next several days, ...

A researcher says the experimental use of gene therapy for a rare inherited disorder is saving almost as much money for ...

Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...

Breast cancer often relapses in distant organs even when complete regression of primary tumors is achieved after initial ...

The global erythropoietin drugs market was valued at approximately USD 6.87 billion in 2022 and is projected to grow at a healthy growth rate of around 1.5% during the forecast period from 2023 to ...

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A war weapon used in World War One went on to become a key component in treating blood cancer with chemotherapy ...

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.